Loading
Linical Co., Ltd., founded in 2005, is a listed company based in Osaka Prefecture, Japan. Its directors and officers file their transactions with EDINET (Japan FSA). From 18 October 2025 to 18 October 2026, the disclosure feed for Linical Co., Ltd. logged 3 filings by 1 insider.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
For context, the typical company on the same exchange (median of 3,419 companies) published 3 filings over the same period, against 3 filings here.
There has been no open-market purchase by an insider of Linical Co., Ltd. for at least a year. Between a trade and the moment it shows up on EDINET (Japan FSA), the median delay is 10 days. That lag is the time during which only the insider knows about the trade.
This summary is built from EDINET (Japan FSA) disclosures alone and does not predict where the share price will go.
Headquarters: Osaka Prefecture, Japan · Founded: 2005
Source: Wikidata (CC0).
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended March 2026 · cache
3 of 3 declarations
Lynical Co., Ltd. is a Japanese company listed on the XTKS market, specializing in clinical research services and drug development. It provides solutions for clinical trials and medical data management.